Authors

• Viktor Grünwald (ORCID: https://orcid.org/0000-0003-2083-7687)
• Filippo de Braud (ORCID: https://orcid.org/0000-0003-0103-730X)
• Peter Ellinghaus
• Marco Maruzzo (ORCID: https://orcid.org/0000-0002-6256-9249)
• Tatiane Cristine Ishida (ORCID: https://orcid.org/0000-0002-2976-0295)
• Johannes Meran (ORCID: https://orcid.org/0009-0007-5690-4382)
• Jonathan E. Rosenberg (ORCID: https://orcid.org/0000-0003-2637-4249)
• Nicolas Penel (ORCID: https://orcid.org/0000-0001-5243-1548)
• Jae‐Lyun Lee (ORCID: https://orcid.org/0000-0002-9420-7162)
• Rafael Morales‐Barrera (ORCID: https://orcid.org/0000-0001-7398-0685)
• Pablo Gajate (ORCID: https://orcid.org/0000-0001-5156-7080)
• Randy F. Sweis (ORCID: https://orcid.org/0000-0002-0497-9637)
• Andrea Necchi (ORCID: https://orcid.org/0000-0002-3007-2756)
• Weichao Bao (ORCID: https://orcid.org/0000-0001-8459-0594)
• Yinghui Zhou (ORCID: https://orcid.org/0000-0003-1548-3474)

Institutions

• Ulsan College (KR)
• Universitat Autònoma de Barcelona (ES)
• Memorial Sloan Kettering Cancer Center (US)
• Bayer (United States) (US)
• Vita-Salute San Raffaele University (IT)
• Merck KGaA, Darmstadt (Germany) (DE)
• Instituto Cajal (ES)
• Université de Lille (FR)
• Asan Medical Center (KR)
• University of Chicago (US)
• University of Ulsan (KR)
• Istituto Oncologico Veneto (IT)
• Essen University Hospital (DE)
• Hospital of the Brothers of St. John of God (AT)
• Vall d'Hebron Hospital Universitari (ES)
• Centre Oscar Lambret (FR)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
• Bayer (Germany) (DE)

Publication Details

Journal

JAMA Oncology

Published

2024-09-19

DOI

https://doi.org/10.1001/jamaoncol.2024.3900

Citations

10

Primary Topic

Bladder and Urothelial Cancer Treatments

Type

article

Field-Weighted Citation Impact

5.73

Funders

• National Cancer Institute